HLN.L vs PBH
HLN.L: A leading global consumer healthcare business managing a portfolio of world-class brands in pain relief, oral health, and wellness. PBH: Prestige Consumer Healthcare is a branded over-the-counter consumer health products company focused on eye care, pain relief, and other wellness categories with a portfolio of established brands.
Side-by-side fundamentals
| Metric | HLN.L | PBH | Edge |
|---|---|---|---|
| Price as of 2026-08-03 close | £3.62 | $52.98 | |
| Market cap as of 2026-08-06 | n/a | $2.5B | |
| P/E as of 2026-08-06 | n/a | 13.11 | |
| Net margin as of 2026-08-06 | n/a | +17.5% | |
| Gross margin as of 2026-08-06 | n/a | +54.7% | |
| Operating margin as of 2026-08-06 | n/a | +28.4% | |
| ROE as of 2026-08-06 | n/a | +10.3% | |
| ROA as of 2026-08-06 | n/a | +5.5% | |
| Debt / equity as of 2026-08-06 | n/a | 0.54 | |
| Revenue growth (YoY) as of 2026-08-06 | n/a | -4.3% | |
| Revenue CAGR (3y) SEC XBRL | n/a | -1.2% | |
| Beta as of 2026-08-06 | n/a | 0.33 | |
| 1-year return as of 2026-08-03 close | -0.8% | -28.4% | HLN.L higher |
Fundamentals: market data, as of 2026-08-06. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-03.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.